–
BriaCell Therapeutics Corp.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−6.98
FY22:
−15.3
FY23:
−23.3
FY24:
−33.3
FY25:
−27.2
(positive)
Change from FY23 to FY24
millions USD
FY21:
–
FY22:
–
FY23:
−25.3
FY24:
−33.1
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.8
FY22:
−26.8
FY23:
20.3
FY24:
4.93
FY25:
26.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.8
FY22:
−26.8
FY23:
−20.3
FY24:
−4.79
FY25:
−26.3
All amounts in millions USD